Close

Analyst Ratings for Ironwood Pharmaceuticals (IRWD) [Sells]

IRWD Rating Summary

IRWD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IRWD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $17.08 (+124.5%) * Over Last 12-Mos
Rating Score: 5.2 / 10   Percentile Rank: 57%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/5/2018 BofA Securities N/A Downgrade Underperform
(Buy)
15.00
(20.00)
15.20
(7.61)
-49.93% Details
1/16/2013 UBS N/A Downgrade Sell
(Neutral)
N/A
(N/A)
14.69
(7.61)
-48.2% Details